Femasys
FEMY
Femasys (FEMY) news
Recent news
Femasys - FemBloc approved for marketing in Europe and select international markets
Femasys Inc. (NASDAQ: FEMY) has secured regulatory approvals for its FemBloc® non-surgical permanent birth control in multiple international markets, including the European Economic Area, the United Kingdom, and New Zealand. The European CE mark was granted in June 2025 under the EU Medical Device…
AInvest Wire · Aug 19, 2026Femasys announces financial results for quarter ended June 30, 2026 and provides corporate update
AInvest Wire · Aug 14, 2026Femasys secures $30 million private placement, with potential proceeds of up to $90 million
AInvest Wire · Aug 7, 2026Femasys regains compliance with Nasdaq listing requirements
AInvest Wire · Jun 24, 2026Femasys - announces 1-for-20 reverse stock split effective June 5, 2026 - SEC filing
AInvest Wire · Jun 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.